We are live on ! Find out more
FCM

Findell Capital Management Portfolio holdings

AUM $710M
1-Year Est. Return 250.3%
This Fund
S&P 500
This Quarter Est. Return
+50.71%
1 Year Est. Return
+250.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$253M
AUM Growth
+$48M
Cap. Flow
+$12.6M
Cap. Flow %
4.96%
Top 10 Hldgs %
90.3%
Holding
20
New
8
Increased
1
Reduced
6
Closed
5

Top Buys

Rank Stock Value
1
DAVE icon
Dave Inc
DAVE
+$8.21M
2
TPB icon
Turning Point Brands
TPB
+$8.15M
3
SGHC icon
SGHC Ltd
SGHC
+$7.89M
4
SEZL
Sezzle
SEZL
+$6.2M
5
MLYS icon
Mineralys Therapeutics
MLYS
+$5.41M

Top Sells

Rank Stock Value
1
ODP
ODP
ODP
+$15.8M
2
VAL icon
Valaris
VAL
+$12.6M
3
AEVA
Aeva Technologies
AEVA
+$7.56M
4
CC icon
Chemours
CC
+$7.45M
5
DAVA icon
Endava
DAVA
+$5.82M

Sector Composition

Rank Sector Weight
1 Healthcare 51.44%
2 Financials 12.15%
3 Consumer Discretionary 9.36%
4 Industrials 4.53%
5 Consumer Staples 3.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LQDA icon
1
Liquidia Corp
LQDA
$6.74B
$64.4M 25.4%
2,830,000
-170,000
-6% -$3.69M
ESTA icon
2
Establishment Labs
ESTA
$2.25B
$53.1M 20.96%
1,295,420
-84,060
-6% -$3.43M
LQDA icon
3
PUT
Liquidia Corp
LQDA
$6.74B
$34.3M 13.55%
+1,510,200
New +$32.8M
OPRT icon
4
Oportun Financial
OPRT
$337M
$15.8M 6.25%
2,568,300
-268,000
-9% -$1.73M
ODP
5
DELISTED
ODP
ODP
$14.9M 5.87%
534,000
-771,000
-59% -$15.8M
GEO icon
6
The GEO Group
GEO
$4.04B
$11.5M 4.53%
560,000
-20,000
-3% -$457K
MLYS icon
7
Mineralys Therapeutics
MLYS
$2.38B
$9.48M 3.74%
+250,000
New +$5.41M
TPB icon
8
Turning Point Brands
TPB
$1.77B
$8.9M 3.51%
+90,000
New +$8.15M
SGHC icon
9
SGHC Ltd
SGHC
$6.69B
$8.85M 3.49%
+670,099
New +$7.89M
DAVE icon
10
Dave Inc
DAVE
$4.4B
$7.58M 2.99%
+38,000
New +$8.21M
BTU icon
11
Peabody Energy
BTU
$3.27B
$6.23M 2.46%
+235,000
New +$4.19M
ROOT icon
12
Root
ROOT
$875M
$5.37M 2.12%
60,000
-27,917
-32% -$2.93M
EHTH icon
13
eHealth
EHTH
$39.7M
$5.28M 2.08%
1,225,000
+25,000
+2% +$96K
SEZL
14
Sezzle
SEZL
$3.95B
$4.29M 1.7%
+54,000
New +$6.2M
ABVX
15
Abivax
ABVX
$10.3B
$3.4M 1.34%
+40,000
New +$2.45M
AEVA
16
Aeva Technologies
AEVA
$1.32B
-200,000
Closed -$7.56M
CC icon
17
Chemours
CC
$2.36B
-651,000
Closed -$7.45M
DAVA icon
18
Endava
DAVA
$162M
-380,000
Closed -$5.82M
LQDA icon
19
CALL
Liquidia Corp
LQDA
$6.74B
-100,000
Closed -$1.25M
VAL icon
20
Valaris
VAL
$6.04B
-300,000
Closed -$12.6M

Similar funds

Findell Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Findell Capital Management held 20 positions worth $253M, up 23% from $205M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Findell Capital Management deployed $12.6M of net new capital in Q3 2025, opening 8 new positions and adding to 1 existing holding. Its largest new stake was Dave Inc: 38,000 shares worth $7.58M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 47% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was ODP, an estimated $15.8M trimmed.

  • Findell Capital Management's largest Q3 2025 buy was Dave Inc: 38,000 shares worth $7.58M.
  • Findell Capital Management added most to eHealth in Q3 2025, an estimated $96K increase.
  • Findell Capital Management's biggest Q3 2025 reduction was ODP, cutting an estimated $15.8M.
  • Findell Capital Management fully exited Valaris in Q3 2025, selling an estimated $12.6M.
  • Findell Capital Management's ten largest holdings make up 90% of its $253M portfolio in Q3 2025.
  • Findell Capital Management opened 8 new positions and closed 5 in Q3 2025.
  • Findell Capital Management's portfolio value rose 23% quarter-over-quarter to $253M.

Based on Findell Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.